tiprankstipranks
Collegium Pharmaceutical Inc. (COLL)
NASDAQ:COLL
US Market
COLL
Collegium Pharmaceutical
RESEARCH TOOLSreports
Want to see COLL full AI Analyst Report?

Collegium Pharmaceutical (COLL) Ratios

502 Followers

Collegium Pharmaceutical Ratios

COLL's free cash flow for Q2 2026 was $0.55. For the 2026 fiscal year, COLL's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.03 1.57 0.95 1.17 0.97
Quick Ratio
 0.84 1.48 0.88 1.10 0.86
Cash Ratio
 0.22 0.57 0.14 0.52 0.40
Solvency Ratio
 0.22 0.21 0.17 0.21 0.12
Operating Cash Flow Ratio
 0.56 0.75 0.40 0.60 0.29
Short-Term Operating Cash Flow Coverage
 6.00 10.83 3.17 1.50 0.76
Net Current Asset Value
$ -1.22B$ -663.75M$ -952.49M$ -410.28M$ -559.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.40 0.57 0.52 0.59 0.60
Debt-to-Equity Ratio
 2.75 3.12 3.75 3.45 3.64
Debt-to-Capital Ratio
 0.73 0.76 0.79 0.78 0.78
Long-Term Debt-to-Capital Ratio
 0.72 0.75 0.77 0.71 0.73
Financial Leverage Ratio
 6.85 5.49 7.27 5.85 6.03
Debt Service Coverage Ratio
 2.57 3.29 2.25 1.05 0.78
Interest Coverage Ratio
 0.98 2.27 2.30 2.00 0.53
Debt to Market Cap
 0.97 0.64 0.92 0.64 0.89
Interest Debt Per Share
 31.41 32.26 28.92 22.45 22.83
Net Debt to EBITDA
 1.24 1.72 2.31 1.41 3.09
Profitability Margins
Gross Profit Margin
60.02%59.35%59.76%57.55%45.15%
EBIT Margin
29.65%22.41%27.32%28.07%7.41%
EBITDA Margin
72.58%51.37%54.11%54.40%37.36%
Operating Profit Margin
19.61%23.97%26.91%29.46%7.18%
Pretax Profit Margin
9.61%11.87%15.61%13.36%-6.22%
Net Profit Margin
5.93%8.05%10.96%8.50%-5.39%
Continuous Operations Profit Margin
5.93%8.05%10.96%8.50%-5.39%
Net Income Per EBT
61.68%67.88%70.20%63.59%86.67%
EBT Per EBIT
49.01%49.51%58.02%45.36%-86.58%
Return on Assets (ROA)
2.24%3.79%4.16%4.21%-2.13%
Return on Equity (ROE)
15.96%20.84%30.23%24.64%-12.83%
Return on Capital Employed (ROCE)
10.25%15.38%14.72%24.36%4.50%
Return on Invested Capital (ROIC)
6.10%10.18%9.78%12.21%3.19%
Return on Tangible Assets
6.31%7.47%11.35%8.19%-5.29%
Earnings Yield
5.44%4.28%7.48%4.64%-3.19%
Efficiency Ratios
Receivables Turnover
 2.83 3.69 2.76 3.16 2.53
Payables Turnover
 34.97 29.77 64.59 27.68 72.82
Inventory Turnover
 2.85 7.76 7.15 7.44 5.47
Fixed Asset Turnover
 55.95 48.18 31.34 25.75 17.59
Asset Turnover
 0.38 0.47 0.38 0.50 0.40
Working Capital Turnover Ratio
 4.92 6.97 24.09 17.19 41.72
Cash Conversion Cycle
 246.27 133.62 177.53 151.48 205.76
Days of Sales Outstanding
 128.76 98.82 132.10 115.61 144.07
Days of Inventory Outstanding
 127.95 47.06 51.08 49.05 66.71
Days of Payables Outstanding
 10.44 12.26 5.65 13.19 5.01
Operating Cycle
 256.71 145.88 183.18 164.66 210.77
Cash Flow Ratios
Operating Cash Flow Per Share
 10.16 10.39 6.35 8.14 3.67
Free Cash Flow Per Share
 10.11 10.33 6.30 8.13 3.62
CapEx Per Share
 0.05 0.05 0.05 0.01 0.05
Free Cash Flow to Operating Cash Flow
 1.00 0.99 0.99 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
 200.80 189.27 124.08 595.98 76.59
Capital Expenditure Coverage Ratio
 200.80 189.27 124.08 595.98 76.59
Operating Cash Flow Coverage Ratio
 0.38 0.35 0.24 0.41 0.18
Operating Cash Flow to Sales Ratio
 0.41 0.42 0.32 0.48 0.27
Free Cash Flow Yield
37.33%22.31%21.99%26.41%15.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.72 23.38 13.39 21.57 -31.39
Price-to-Sales (P/S) Ratio
 1.09 1.88 1.46 1.83 1.69
Price-to-Book (P/B) Ratio
 2.82 4.87 4.04 5.31 4.03
Price-to-Free Cash Flow (P/FCF) Ratio
 2.68 4.48 4.55 3.79 6.40
Price-to-Operating Cash Flow Ratio
 2.67 4.46 4.51 3.78 6.32
Price-to-Earnings Growth (PEG) Ratio
 0.60 -3.13 0.40 -0.07 0.23
Price-to-Fair Value
 2.82 4.87 4.04 5.31 4.03
Enterprise Value Multiple
 2.74 5.38 5.01 4.78 7.62
Enterprise Value
 1.61B 2.16B 1.71B 1.47B 1.32B
EV to EBITDA
 2.74 5.38 5.01 4.78 7.62
EV to Sales
 1.99 2.76 2.71 2.60 2.85
EV to Free Cash Flow
 4.90 6.59 8.43 5.37 10.77
EV to Operating Cash Flow
 4.87 6.55 8.36 5.36 10.63
Tangible Book Value Per Share
 -32.79 -16.20 -25.56 -10.67 -14.97
Shareholders’ Equity Per Share
 9.61 9.51 7.09 5.79 5.76
Tax and Other Ratios
Effective Tax Rate
 0.38 0.32 0.30 0.36 0.13
Revenue Per Share
 24.90 24.62 19.57 16.80 13.71
Net Income Per Share
 1.48 1.98 2.14 1.43 -0.74
Tax Burden
 0.62 0.68 0.70 0.64 0.87
Interest Burden
 0.32 0.53 0.57 0.48 -0.84
Research & Development to Revenue
 0.00 0.00 0.00 0.00 <0.01
SG&A to Revenue
 0.30 0.35 0.29 0.00 0.00
Stock-Based Compensation to Revenue
 0.06 0.05 0.05 0.05 0.05
Income Quality
 6.89 5.24 2.96 5.71 -4.97
Currency in USD